Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Paul Allan Renhowe is active.

Publication


Featured researches published by Paul Allan Renhowe.


Journal of Biological Chemistry | 2017

Discovery of stimulator binding to a conserved pocket in the heme domain of soluble guanylyl cyclase

Jessica A. Wales; Cheng Yu Chen; Linda Breci; Andrzej Weichsel; Sylvie G. Bernier; James E. Sheppeck; Robert Solinga; Takashi Nakai; Paul Allan Renhowe; Joon Jung; William R. Montfort

Soluble guanylyl cyclase (sGC) is the receptor for nitric oxide and a highly sought-after therapeutic target for the management of cardiovascular diseases. New compounds that stimulate sGC show clinical promise, but where these stimulator compounds bind and how they function remains unknown. Here, using a photolyzable diazirine derivative of a novel stimulator compound, IWP-051, and MS analysis, we localized drug binding to the β1 heme domain of sGC proteins from the hawkmoth Manduca sexta and from human. Covalent attachments to the stimulator were also identified in bacterial homologs of the sGC heme domain, referred to as H-NOX domains, including those from Nostoc sp. PCC 7120, Shewanella oneidensis, Shewanella woodyi, and Clostridium botulinum, indicating that the binding site is highly conserved. The identification of photoaffinity-labeled peptides was aided by a signature MS fragmentation pattern of general applicability for unequivocal identification of covalently attached compounds. Using NMR, we also examined stimulator binding to sGC from M. sexta and bacterial H-NOX homologs. These data indicated that stimulators bind to a conserved cleft between two subdomains in the sGC heme domain. L12W/T48W substitutions within the binding pocket resulted in a 9-fold decrease in drug response, suggesting that the bulkier tryptophan residues directly block stimulator binding. The localization of stimulator binding to the sGC heme domain reported here resolves the longstanding question of where stimulators bind and provides a path forward for drug discovery.


BMC Clinical Pharmacology | 2015

Discovery of IWP-051, a novel orally bioavailable soluble guanylate cyclase stimulator with sustained and dose-dependent hemodynamic effects.

Takashi Nakai; Nicholas Robert Perl; Rajesh R. Iyengar; Ara Mermerian; G-Yoon Jamie Im; Thomas W-H Lee; Glen Robert Rennie; James Jia; Paul Allan Renhowe; Timothy C. Barden; James E. Sheppeck; Karthik Iyer; Joon Jung; G. Todd Milne; Chrissie Segal; Kimberly Long; Joy Miyashiro; Sylvie G. Bernier; Sarah Jacobson; Jenny Tobin; Courtney Shea; Peter Germano; Yueh-tyng Chien; Daniel P. Zimmer

Discovery of IWP-051, a novel orally bioavailable soluble guanylate cyclase stimulator with sustained and dose-dependent hemodynamic effects Takashi Nakai, Nicholas R Perl, Rajesh R Iyengar, Ara Mermerian, G-Yoon J Im, Thomas W-H Lee, Glen R Rennie, James Jia, Paul A Renhowe, Timothy C Barden, James E Sheppeck II, Karthik Iyer, Joon Jung, G Todd Milne, Chrissie Segal, Kimberly Long, Joy Miyashiro, Sylvie Bernier, Sarah Jacobson, Jenny Tobin, Courtney Shea, Peter Germano, Yueh-tyng Chien, Daniel Zimmer


Archive | 2012

2 - benzyl, 3 - (pyrimidin- 2 -yl) substituted pyrazoles useful as sgc stimulators

Charles Kim; Takashi Nakai; Joel Moore; Nicholas Robert Perl; G-Yoon Jamie Im; Timothy C. Barden; Rajesh R. Iyengar; Daniel P. Zimmer; Angelika Fretzen; Paul Allan Renhowe


Archive | 2015

PYRAZOLE DERIVATIVES AS SGC STIMULATORS

Timothy C. Barden; James E. Sheppeck; Glen Robert Rennie; Paul Allan Renhowe; Nicholas Robert Perl; Takashi Nakai; Ara Mermerian; Thomas Wai-Ho Lee; Joon Jung; James Jia; Karthik Iyer; Rajesh R. Iyengar; G-Yoon Jamie Im


Archive | 2012

2-benzyl-3-(oxazole/thiazole)-5-(pyrimidin-2-yl)-1(H)-pyrazole derivatives as stimulators of the soluble guanylate cyclase (sGC) for the treatment of e.g. hypertension or heart failure

Charles Kim; Takashi Nakai; Joel Moore; Nicholas Robert Perl; G-Yoon Jamie Im; Timothy C. Barden; Rajesh R. Iyengar; Daniel P. Zimmer; Angelika Fretzen; Paul Allan Renhowe


Archive | 2018

FUSED BICYCLIC SGC STIMULATORS

Glen Robert Rennie; Rajesh R. Iyengar; Thomas Wai-Ho Lee; Takashi Nakai; Ara Mermerian; Lei Jia; G-Yoon Jamie Im; Paul Allan Renhowe; Joon Jung; Peter Germano; Karthik Iyer; Timothy C. Barden; Kim Tang


Archive | 2017

USE OF sGC STIMULATORS FOR THE TREATMENT OF NONALCOHOLIC STEATOHEPATITIS (NASH)

G-Yoon Jamie Im; Mark G. Currie; James E. Sheppeck; Paul Allan Renhowe; Pei Ge; Jaime L. Masferrer


Archive | 2012

2-[1-[(2-fluorophenyl)methyl]-5-(3-isoxazolyl)-1h-pyrazol-3-yl]-pyrimidine derivatives and related compounds as soluble guanylate cyclase (sgc) stimulators for the treatment of pulmonary hypertension

Charles Kim; Takashi Nakai; Joel Moore; Nicholas Robert Perl; G-yoon Jame Im; Timothy C. Barden; Rajesh R. Iyengar; Daniel P. Zimmer; Angelika Fretzen; Paul Allan Renhowe


Archive | 2012

2-[1-[(2-fluorophenyl)methyl]-5-(3-isoxazolyl)-1h-pyrazol-3-yl]-pyrimidinderivate und verwandte verbindungen als stimulatoren der löslichen guanylatcyclase (lgc) zur behandlung von pulmonarer hypertonie

Charles Kim; Takashi Nakai; Joel D. Moore; Nicholas Robert Perl; G-yoon Jame Im; Timothy C. Barden; Rajesh R. Iyengar; Daniel P. Zimmer; Angelika Fretzen; Paul Allan Renhowe


Archive | 2012

Pyrazoles 2-benzyle, 3-(pyrimidin-2-yle)-substitués utiles comme stimulateurs de scg

Charles Kim; Takashi Nakai; Joel D. Moore; Nicholas Robert Perl; G-Yoon Jamie Im; Timothy C. Barden; Rajesh R. Iyengar; Daniel P. Zimmer; Angelika Fretzen; Paul Allan Renhowe

Collaboration


Dive into the Paul Allan Renhowe's collaboration.

Top Co-Authors

Avatar

Takashi Nakai

Ironwood Pharmaceuticals

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Charles Kim

Ironwood Pharmaceuticals

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Joon Jung

Ironwood Pharmaceuticals

View shared research outputs
Researchain Logo
Decentralizing Knowledge